Action occurs as parent Publicis Groupe acquires leading digital agency, Sapient
Rick Keefer, president and CEO of Publicis Touchpoint Solutions (Yardley, PA) has been promoted to the title of global chief business development officer for Touchpoint’s parent, Publicis Healthcare Communications, which claims the label of “the world’s largest health-oriented communications network.” And that positioning might be about to grow larger as the global parent, Paris-based Publicis Groupe, announced the $3.7-billion acquisition of Sapient, an IT and consulting company deeply embedded in online business/customer interactions, from e-commerce to marketing services.
Michelle Keefe, COO at Touchpoint for the past three years, has been promoted to president. Both Keefer and Keefe have extensive experience at pharma companies and healthcare; prior to Touchpoint, Keefe had been business development manager at the Visiting Nurses Assn., and before that, at Pfizer. Keefer worked at Biovail, Pharmacia and Wyeth-Ayerst prior to joining Touchpoint in 2006; the company says that that unit has grown tenfold in the intervening years. Current services include contract sales, contact centers, employee recruitment and consulting.
While Publicis Healthcare (and Publicis Groupe) have extensive presence in pharma and healthcare, Sapient appears to be less invested. Its services have been directed at government, financial services and global brand management, with an emphasis in online interactivity. Maurice Levy, chairman of Publicis Groupe, while noting that the acquisition will create an $8-billion marketing and advertising giant, said that the acquisition will “leverage technology [and] consulting capabilities to expand in new verticals.” How soon these capabilities might trickle down to Touchpoint will be interesting to watch.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.